A Non-Pathogenic Leishmania Tarentolae Vector Based- Hcv Polytope Dna Vaccine Elicits Potent and Long Lasting Th1 and Ctl Responses in Balb/C Mice Model

A Non-Pathogenic Leishmania Tarentolae Vector Based- Hcv Polytope Dna Vaccine Elicits Potent and Long Lasting Th1 and Ctl Responses in Balb/C Mice Model Publisher Pubmed

Ansari N¹ ; Rafati S² ; Taheri T² ; Roohvand F³ ; Farahmand M¹ ; Hajikhezri Z¹ ; Keshavarz A¹ ; Samimirad K¹

Show Affiliations

1. Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
2. Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran
3. Department of Virology, Pasteur Institute of Iran, Tehran, Iran

Source: Molecular Immunology Published:2019

Abstract

Despite successful anti-viral (DAAs) treatment of Hepatitis C virus (HCV) infection, recent data indicated the need for an effective vaccine. Preexisting anti-vector immunity is an obstacle for application of live vectors for antigen delivery and development of effective T-cell based HCV vaccines. Herein, we report construction of recombinant Leishmania tarentolae, a lizard (non-human) parasite, expressing an HCV polytope DNA, PT-NT(gp96), encoding for several immunogenic HCV epitopes and evaluation of its immunogenicity in three different prime/boost immunization groups (G) of BALB/c mice. Homologous prime/boost immunization by L.tarentolae-PT-NT(gp96) either with or without CpG (G1 and G2 respectively) and heterologous immunization with a PT-NT(gp96) encoding-pCDNA plasmid followed by L.tarentolae-PT-NT (G3) was undertaken. Immune responses were measured three and nine weeks (W) post immunization. Splenocytes (cultured with antigen-stimulant) of mice in G1 showed the highest percentage of specific CTL-cytolytic activity compared to G2 and G3 at both short (W3:70.98% versus 41.29% and 13.12%) and long (W9: 50% versus 24.5% and 20%) term periods, accompanied with high levels of secreted IFN-γ. Comparison of IFN-γ, IL-4, IL-17 and TNF-α cytokines levels obtained from the supernatant of antigen-stimulated splenocytes as well as antibodies level (as IgG1/IgG2a ratio; obtained from sera of immunized mice) indicated higher Th1 oriented responses for G1, G2 groups and balanced Th1-Th17 for G3. Results indicated the potential of L.tarentolae (+CpG), as a non-pathogenic live vaccine vector, for delivery and enhancement of immune responses against HCV-polytope antigens. © 2019 Elsevier Ltd

Related Docs

View other Related Docs

1. Leishmania Tarentolae Secreting the Sand Fly Salivary Antigen Ppsp15 Confers Protection Against Leishmania Major Infection in a Susceptible Balb/C Mice Model, Molecular Immunology (2015)

2. A Live Vector Expressing Hpv16 L1 Generates an Adjuvant-Induced Antibody Response In-Vivo, International Journal of Cancer Management (2015)

3. Delivery Systems for Leishmania Vaccine Development, Expert Review of Vaccines (2016)

4. A Dna Vaccine Expressing Fusion Protein E2-Nt(Gp96) Induces Hepatitis C Virus Cross-Neutralizing Antibody in Balb/C Mice, Hepatitis Monthly (2019)

5. Hepatitis C Virus Dna Vaccines: A Systematic Review, Virology Journal (2021)

6. Preparation of Transgenic Iranian Lizard Leishmania Coding Hil-12, Iranian Journal of Microbiology (2017)

7. Hcv Core/Ns3 Protein Immunization With “N-Terminal Heat Shock Gp96 Protein (Rnt (Gp96))” Induced Strong and Sustained Th1-Type Cytokines in Immunized Mice, Vaccines (2021)

8. Assessment of a Poly-Epitope Candidate Vaccine Against Hepatitis B, C, and Poliovirus in Interaction With Monocyte-Derived Dendritic Cells: An Ex-Vivo Study, Human Immunology (2020)

Experts (# of related papers)

View all Related Experts

Katayoun Samimi Rad (3)

Ali Akbar Amirzargar (2)

Style	Citing Format
MLA	Ansari N, et al.. "A Non-Pathogenic Leishmania Tarentolae Vector Based- Hcv Polytope Dna Vaccine Elicits Potent and Long Lasting Th1 and Ctl Responses in Balb/C Mice Model." Molecular Immunology, vol. 111, no. , 2019, pp. 152-161.
APA	Ansari N, Rafati S, Taheri T, Roohvand F, Farahmand M, Hajikhezri Z, Keshavarz A, Samimirad K (2019). A Non-Pathogenic Leishmania Tarentolae Vector Based- Hcv Polytope Dna Vaccine Elicits Potent and Long Lasting Th1 and Ctl Responses in Balb/C Mice Model. Molecular Immunology, 111(), 152-161.
Chicago	Ansari N, Rafati S, Taheri T, Roohvand F, Farahmand M, Hajikhezri Z, Keshavarz A, Samimirad K. "A Non-Pathogenic Leishmania Tarentolae Vector Based- Hcv Polytope Dna Vaccine Elicits Potent and Long Lasting Th1 and Ctl Responses in Balb/C Mice Model." Molecular Immunology 111, no. (2019): 152-161.
Harvard	Ansari N et al. (2019) 'A Non-Pathogenic Leishmania Tarentolae Vector Based- Hcv Polytope Dna Vaccine Elicits Potent and Long Lasting Th1 and Ctl Responses in Balb/C Mice Model', Molecular Immunology, 111(), pp. 152-161.
Vancouver	Ansari N, Rafati S, Taheri T, Roohvand F, Farahmand M, Hajikhezri Z, et al.. A Non-Pathogenic Leishmania Tarentolae Vector Based- Hcv Polytope Dna Vaccine Elicits Potent and Long Lasting Th1 and Ctl Responses in Balb/C Mice Model. Molecular Immunology. 2019;111():152-161.
BibTex	@article{ author = {Ansari N and Rafati S and Taheri T and Roohvand F and Farahmand M and Hajikhezri Z and Keshavarz A and Samimirad K}, title = {A Non-Pathogenic Leishmania Tarentolae Vector Based- Hcv Polytope Dna Vaccine Elicits Potent and Long Lasting Th1 and Ctl Responses in Balb/C Mice Model}, journal = {Molecular Immunology}, volume = {111}, number = {}, pages = {152-161}, year = {2019} }
RIS	TY - JOUR AU - Ansari N AU - Rafati S AU - Taheri T AU - Roohvand F AU - Farahmand M AU - Hajikhezri Z AU - Keshavarz A AU - Samimirad K TI - A Non-Pathogenic Leishmania Tarentolae Vector Based- Hcv Polytope Dna Vaccine Elicits Potent and Long Lasting Th1 and Ctl Responses in Balb/C Mice Model JO - Molecular Immunology VL - 111 IS - SP - 152 EP - 161 PY - 2019 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract